The Affordable Inhalers and Nebulizers Act of 2025 limits patient costs for prescription inhalers and related equipment used to treat asthma and chronic obstructive pulmonary disease (COPD). Under the bill, private health insurance plans, Medicare, and high-deductible health plans must cover inhalers without applying a deductible and cap out-of-pocket costs at $15 per 30-day supply, with these costs counting toward annual out-of-pocket maximums. The bill also establishes a payment program beginning January 1, 2026, to help uninsured individuals access inhalers at no more than $15 per month's supply, with the federal government covering provider costs through reimbursement. These provisions apply to all maintenance, relief, and rescue inhalation drugs, including nebulizers, spacers, and related equipment used to administer them. The legislation takes effect for plan years beginning on or after January 1, 2026, and is funded through existing appropriations or new funding designated by Congress.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.